Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Performance share units −3,000 9,000
2026-06-18 Milanova Tsveta Chief Commercial Officer Grant or award · Restricted stock units +3,000 3,000
2026-04-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +8,500 50,091
2026-04-02 Milanova Tsveta Chief Commercial Officer Sale 10b5-1 −3,262 $34.71 $113K 46,829
2026-04-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Performance share units 10b5-1 −8,500 8,500
2026-03-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +5,666 40,459
2026-03-02 Milanova Tsveta Chief Commercial Officer Sale 10b5-1 −1,681 $28.96 $49K 38,778
2026-03-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +4,000 42,778
2026-03-02 Milanova Tsveta Chief Commercial Officer Sale 10b5-1 −1,187 $28.96 $34K 41,591
2026-03-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Restricted stock units 10b5-1 −5,666 5,667
2026-03-02 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Restricted stock units 10b5-1 −4,000 8,000
2026-03-01 Milanova Tsveta Chief Commercial Officer Grant or award · Restricted stock units 10b5-1 +14,000 14,000
2026-03-01 Milanova Tsveta Chief Commercial Officer Grant or award · Stock options (right to buy) 10b5-1 +52,000 52,000
2026-01-05 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +8,475 37,665
2026-01-05 Milanova Tsveta Chief Commercial Officer Sale 10b5-1 −2,872 $27.02 $78K 34,793
2026-01-05 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Restricted stock units 10b5-1 −8,475 0
2025-12-30 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +6,000 32,122
2025-12-30 Milanova Tsveta Chief Commercial Officer Sale 10b5-1 −2,932 $27.09 $79K 29,190
2025-12-30 Milanova Tsveta Chief Commercial Officer Exercise or conversion · Performance share units 10b5-1 −6,000 0
2025-06-24 Milanova Tsveta Chief Commercial Officer Exercise or conversion 10b5-1 +6,000 28,892

Page 1 of 3 · 43 trades